April 25, 2012 >> Read More
Actos News
European Medicines Agency Recommends New Warnings for Actos Bladder Cancer Risk
Thursday, April 19, 2012
Texas - Actos Bladder Cancer Information
Friday, April 13, 2012
This is an alert to diabetes patients in Texas that Pioglitazone, the main ingredient in the diabetes drug Actos, has been linked to a 40 percent increased risk of developing bladder cancer. >> Read More
Florida Actos Bladder Cancer Information
Monday, April 02, 2012
If you live in Florida and are taking the diabetes medication Actos, please be aware that the Food and Drug Administration has warned of a link between the diabetes drug Actos and bladder cancer. According to the agency, cumulative doses and long-term use of Takeda Pharmaceutical’s popular diabetes drug Actos (pioglitazone) has been linked with a significantly higher risk of developing the deadly form of cancer. >> Read More
Baum Hedlund Files Federal Actos Bladder Cancer Lawsuit On Behalf Of Virginia Couple
Monday, March 26, 2012
Actos Manufacturer Evaded Reporting Actos Bladder Cancers and Congestive Heart Failures, According to Former Takeda Medical Reviewer
Tuesday, March 20, 2012
Actos manufacturers failed to disclose a risk of bladder cancer
Wednesday, January 11, 2012
